>
Switch to:

Eidos Therapeutics Marketable Securities

: $0.00 Mil (As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Eidos Therapeutics's marketable securities for the quarter that ended in Sep. 2020 was $0.00 Mil.


Eidos Therapeutics Marketable Securities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Marketable Securities 0.00 0.00 0.00 0.00

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Marketable Securities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eidos Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Eidos Therapeutics  (NAS:EIDX) Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' marketable securities also includes "Other Short Term Investment".


Eidos Therapeutics Marketable Securities Related Terms


Eidos Therapeutics Marketable Securities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)